Oxidation/reduction of thiol residues in proteins is an important type of post-translational modification that is implicated in regulating a range of biological processes. The nature of the modification makes it possible to define a quantifiable electrochemical potential, ⊕ , for oxidation/reduction that allows cysteine-containing proteins to be ranked based on their propensity to be oxidized. Measuring oxidation of cysteine residues in proteins is difficult using standard electrochemical methods but recently top-down mass-spectrometry has been shown to enable the quantification of ⊕ for thiol oxidations. In this paper we demonstrate that mass spectrometry of intact proteins can be used in combination with an isotopic labeling strategy and an automated data analysis algorithm to measure ⊕ for the thiols in both E Coli Thioredoxin 1 and Human Thioredoxin 1. Our methodology relies on accurate mass measurement of proteins using LC-MS analyses and does not necessarily require top-down fragmentation. As well as analyzing homogeneous protein samples, we also demonstrate that our methodology can be used to determine thiol ⊕ measurements in samples which contain mixtures of proteins. Thus the combination of experiential methodology and data analysis regime have the potential to make such measurements in a high-throughput manner and in a manner more accessible to a broad community of protein scientists.Over the past three decades oxidative thiol modification has emerged as a central mechanism for dynamic post-translational regulation of protein activity and protein signaling pathways. In 1992, Stamler et al. investigated the S-nitrosylation of protein cysteine thiols as a reversible covalent modification important in vasodilation. 1 In 2000, Finkel published a review article in which he suggested 'the covalent addition of glutathione to reactive cysteines may be one mechanism for achieving reversible redox-dependent signaling as well as a potential means for identifying relevant redox-dependent signaling molecules. 2 Since then, it has become apparent that many important biological pathways are subject to redox regulation through such oxidation-reduction reactions. [3][4][5] For example, in the intrinsic apoptotic pathway, the apoptosis regulator protein Bax has been shown to undergo oxidative activation through disulfide formation; and activation of the initiator caspase Casp9 has been shown to occur via intermolecular disulfide formation with apoptotic protease activating factor 1 (APAF1). 6,7 Interestingly, redox regulation seems to be particularly prevalent amongst transcription factors (TF), where cysteine modifications can control function via several mechanisms. For example, in the AP-1 family of TFs, Cys oxidation has been shown to induce conformational change, inhibiting DNA-binding. 8 In contrast, Nuclear factor-like 2 (NRF2) activity is controlled by oxidation of its partner protein KEAP1; disulfide formation in KEAP1 results in a reduced affinity for NRF2, allowing translocation of NRF2 into the nuc...